Incanthera
Liverpool
About Incanthera
Incanthera Ltd. develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific matrix metalloprotease enzyme. The company was incorporated in 2010 and is based in Liverpool, United Kingdom.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $4.4M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jun 2024)
- Ticker: lse:INC
- Website: incanthera.com
- Phone: +44 151-331-5220
Industries & Categories
Biopharma, Biotechnology, Medical, Oncology
Canonical: https://fsome.com/organization/incanthera-49488 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.